Artikel ; Online: Understanding the Cellular Sources of the Fractional Exhaled Nitric Oxide (FeNO) and Its Role as a Biomarker of Type 2 Inflammation in Asthma.
2022 Band 2022, Seite(n) 5753524
Abstract: Fractional exhaled nitric oxide (FeNO) has gained great clinical importance as a biomarker of type 2 inflammation in chronic airway diseases such as asthma. FeNO originates primarily in the bronchial epithelium and is produced in large quantities by the ... ...
Abstract | Fractional exhaled nitric oxide (FeNO) has gained great clinical importance as a biomarker of type 2 inflammation in chronic airway diseases such as asthma. FeNO originates primarily in the bronchial epithelium and is produced in large quantities by the enzyme inducible nitric oxide synthase (iNOS). It should be noted that nitric oxide (NO) produced at femtomolar to picomolar levels is fundamental for respiratory physiology. This basal production is induced in the bronchial epithelium by interferon gamma (IFN |
---|---|
Mesh-Begriff(e) | Asthma/drug therapy ; Biomarkers/metabolism ; Breath Tests ; Exhalation ; Fractional Exhaled Nitric Oxide Testing ; Humans ; Inflammation ; Nitric Oxide/metabolism |
Chemische Substanzen | Biomarkers ; Nitric Oxide (31C4KY9ESH) |
Sprache | Englisch |
Erscheinungsdatum | 2022-05-02 |
Erscheinungsland | United States |
Dokumenttyp | Journal Article ; Review |
ZDB-ID | 2698540-8 |
ISSN | 2314-6141 ; 2314-6133 |
ISSN (online) | 2314-6141 |
ISSN | 2314-6133 |
DOI | 10.1155/2022/5753524 |
Datenquelle | MEDical Literature Analysis and Retrieval System OnLINE |
Zusatzmaterialien
Kategorien
Über subito bestellen
Dieser Service ist kostenpflichtig (siehe Lieferbedingungen von subito). Bestellungen, die einen Artikel nebst Supplementary Material umfassen, werden grundsätzlich wie mehrfache Bestellungen bearbeitet. Gebühren fallen in diesen Fällen für jede einzelne Bestellung an.